SHREE GANESH REMEDIES
Back to Income Statement
|
SHREE GANESH REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Consolidated Net Profit | ₹28 Cr | ₹1,047,056 Cr | ₹6.24 Cr | ₹6.24 Cr |
What is the latest Consolidated Net Profit of SHREE GANESH REMEDIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹1,047,056 Cr |
| Mar2020 | ₹6.24 Cr |
| Mar2019 | ₹6.24 Cr |
How is Consolidated Net Profit of SHREE GANESH REMEDIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹28 Cr | -100.00 | |
| Mar2024 | ₹1,047,056 Cr | 16,793,096.95 | |
| Mar2020 | ₹6.24 Cr | 0.00 | |
| Mar2019 | ₹6.24 Cr | - | |
Compare Consolidated Net Profit of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹542.7 Cr | 5.9% | -8.5% | -36.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,341.0 Cr | -1.8% | -6.4% | -10.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,401.0 Cr | -0.3% | -5.5% | 8.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,175.0 Cr | -0.1% | 4% | 18.7% | Stock Analytics | |
| CIPLA | ₹107,100.0 Cr | 1% | -12.3% | -5.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,715.9 Cr | -4.6% | -7% | 1.8% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 5.9% |
-8.5% |
-36.9% |
| SENSEX | -1% |
-4.7% |
6% |
You may also like the below Video Courses